Its long half-life creates a “self-tapering” effect, providing sustained symptom control and reducing the risk of breakthrough symptoms or rebound withdrawal that can occur with shorter-acting agents. Instead of directly binding to GABA receptors, it modulates calcium channel activity in the brain. This action calms hyperexcited neurons, which are a ...
| Play | Cover | Release Label |
Track Title Track Authors |
|---|